Return to study ST001467 main page

Download data matrix(Metabolites changes related to glucose-mediated energy production in chemotheraphy-induced cachexia Reversed phase NEGATIVE ION MODE)

Download data matrix(Metabolites changes related to glucose-mediated energy production in chemotheraphy-induced cachexia Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODE5FU_1m_2Group:batch1 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_2m_2Group:batch1 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_3m_2Group:batch1 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_1p_2Group:batch1 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODE5FU_2p_2Group:batch1 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODE5FU_3p_2Group:batch1 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_1m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_2m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_3m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_1m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_2m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_3m_2Group:batch1 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_1p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_2p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_3p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_1p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_2p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_3p_2Group:batch1 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_1m_2Group:batch1 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_2m_2Group:batch1 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_1m_2Group:batch1 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_2m_2Group:batch1 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_3m_2Group:batch1 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_1p_2Group:batch1 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_2p_2Group:batch1 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_1p_2Group:batch1 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_2p_2Group:batch1 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_3p_2Group:batch1 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODE5FU_4m_2Group:batch2 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_5m_2Group:batch2 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_6m_2Group:batch2 | Treatment:5FU | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODE5FU_4p_2Group:batch2 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODE5FU_5p_2Group:batch2 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODE5FU_6p_2Group:batch2 | Treatment:5FU | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_4m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_5m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_6m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_4m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_5m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST200_6m_2Group:batch2 | Treatment:BST204 | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODEBST100_4p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_5p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST100_6p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_4p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_5p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODEBST200_6p_2Group:batch2 | Treatment:BST204 | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_3m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_4m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_5m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_6m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_4m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_5m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODETB_6m_2Group:batch2 | Treatment:Control | Sample Source:musclePeak area ratio
Reversed phase NEGATIVE ION MODENTB_3p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_4p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_5p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODENTB_6p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_4p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_5p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase NEGATIVE ION MODETB_6p_2Group:batch2 | Treatment:Control | Sample Source:plasmaPeak area ratio
Reversed phase POSITIVE ION MODE5FU_1mGroup:batch1 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_2mGroup:batch1 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_3mGroup:batch1 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_1pGroup:batch1 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_2pGroup:batch1 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_3pGroup:batch1 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_1mGroup:batch1 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_2mGroup:batch1 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_3mGroup:batch1 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_1mGroup:batch1 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_2mGroup:batch1 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_1pGroup:batch1 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_2pGroup:batch1 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_1pGroup:batch1 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_2pGroup:batch1 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_3pGroup:batch1 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_1mGroup:batch1 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_2mGroup:batch1 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_1mGroup:batch1 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_2mGroup:batch1 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_3mGroup:batch1 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_1pGroup:batch1 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_2pGroup:batch1 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_1pGroup:batch1 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_2pGroup:batch1 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_3pGroup:batch1 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_4mGroup:batch2 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_5mGroup:batch2 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_6mGroup:batch2 | Treatment:5FU | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_4pGroup:batch2 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_5pGroup:batch2 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODE5FU_6pGroup:batch2 | Treatment:5FU | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_4mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_5mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_6mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_3mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_4mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_5mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_6mGroup:batch2 | Treatment:BST204 | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_3pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_4pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_5pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST100_6pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_4pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_5pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODEBST200_6pGroup:batch2 | Treatment:BST204 | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_3mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_4mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_5mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_6mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_4mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_5mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_6mGroup:batch2 | Treatment:Control | Sample Source:muscleuL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_3pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_4pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_5pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODENTB_6pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_4pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_5pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
Reversed phase POSITIVE ION MODETB_6pGroup:batch2 | Treatment:Control | Sample Source:plasmauL(plasma), pmole/mg (muscle)
  logo